Professor Karen Puopolo MD, PhD
Karen M. Puopolo is a neonatologist who specializes in neonatal infectious diseases. She received her undergraduate degree in physics from Yale University in New Haven, Connecticut, and went on to obtain her MD as well as a PhD in molecular physiology from the Tufts University School of Medicine in Boston, Massachusetts. She completed Pediatric residency and Neonatal-Perinatal fellowship training at Boston Children’s Hospital. Upon completing her fellowship, Dr. Puopolo was appointed to the faculty of Harvard Medical School and joined the staff of the Brigham and Women’s Hospital and the Channing Laboratory, where she was an attending neonatologist and researcher from 2000-2014. Dr. Puopolo began her neonatal research career as a laboratory-based scientist investigating mechanisms of virulence in Group B Streptococcus (GBS). More recently her research has focused on the epidemiology of neonatal infection, with an emphasis on molecular epidemiology and risk assessment. Recent publications focus on the results of NIH-funded research describing the results of the largest case-control study of risk factors for neonatal early-onset sepsis done in the era of GBS prophylaxis. Dr. Puopolo is an elected member of the Society for Pediatric Research and the American Pediatric Society. She serves on the editorial board for NeoReviews. In addition, she serves on the American Academy of Pediatrics Committee on the Fetus and Newborn, whose members study issues and current advances in fetal and neonatal care and make recommendations regarding national neonatal practice. Dr. Puopolo is currently on the faculty of the University of Pennsylvania Perelman School of Medicine. She is a member of the Division of Neonatology at Children’s Hospital of Philadelphia, and Section Chief for Newborn Pediatrics at Pennsylvania Hospital.
Professor Lucy Chappell
Professor Lucy Chappell is NIHR Research Professor in Obstetrics at King’s College London and Honorary Consultant Obstetrician at Guy’s and St Thomas’ NHS Foundation Trust. She runs a research programme investigating prediction and prevention of adverse pregnancy outcomes, particularly in women with pre-existing co-morbidities such as chronic hypertension and chronic kidney disease, using randomised controlled trials and observational studies. She has subspecialty training in maternal-fetal medicine and a Masters in higher education. She is lead for Integrated Academic Training in Obstetrics and Gynaecology at King’s College London, joint R&D lead for Women’s Health and on the PLoS Medicine editorial board. Her research interest include the study of urinary proteomics in the prediction and diagnosis of pre-eclampsia, prediction of pre-eclampsia in high/low risk women in pregnancy, automated protein urinalysis for hypertensive women in pregnancy
Professor Timothy Draycott
Professor Timothy Draycott is a Consultant Obstetrician with a research interest in patient safety, quality improvement and multi-professional obstetric training. Over the last 15 years he has led the development of a completely new academic department in Obstetrics and Gynaecology at North Bristol that is now recognised as a major international intrapartum and safety research centre – currently with 49 research team members. He has expanded a research portfolio, successfully securing almost £4 million research funding in the last decade, leading large multi-centre NIHR portfolio randomised controlled trials (IMOX study – 6285 women) as well as leading national level studies with innovative trial designs – THISTLE study in Scotland and Odon with the Gates Foundation. With Cathy Winter, he leads the team who developed the PROMPT training programme that has been successfully implemented in over 45 countries across the world and has developed and evaluated an undergraduate PROMPT programme and also a pre-hospital programme. This work was recognised as 4* for impact by the most recent University Research Excellence Framework and the Queen’s Anniversary Award in 2014.
Professor Jason Gardosi MD FRCSED FRCOG
Professor Jason Gardosi is the Director of the Perinatal Institute in Birmingham, UK - a multidisciplinary not-for-profit organisation set up to enhance the quality and safety of maternity care (www.perinatal.org.uk). The Institute is recipient of consecutive national Patient Safety Awards in 2013, 2014 and 2015, the 2015 BMJ Award for Clinical Leadership, and a 2016 Queen’s Award for reducing stillbirth rates in England. Jason’s main interests are fetal growth, antepartum and intrapartum surveillance, perinatal epidemiology and clinical audit.
Dr. Pippa Kyle
Formerly consultant and lead for Fetal Medicine at Guy’s and St. Thomas’s NHS Foundation Trust, Dr Pippa Kyle's previous appointments include Professor of Obstetrics and Gynaecologyat the University of Otago, Christchurch, New Zealand (2003-2008), and Consultant in Obstetrics and Fetal Medicine, Bristol, UK (1996-2003), where she was lead of the regional Fetal Medicine Unit. Dr Kyle undertook her initial training in New Zealand and thereafter in Oxford (MD thesis), Canada, Cambridge, and London (Queen Charlotte’s and Chelsea Hospital). Dr Kyle’s research areas have focused on pre-eclampsia, multiple pregnancy, fetal anaemia, and fetal growth. She has published over 70 scientific peer-reviewed papers and 20 chapters or review articles. Dr Kyle also has developed a special interest in risk management and medicolegal work, of which she undertakes reports for both the civil and coroner’s courts, and she is a member of the Academy of Experts.
Professor Gunnar Naulaers
Prof Gunnar Naulaers graduated as MD at Katholieke Universiteit Leuven (KUL) in 1990.He specialized in pediatrics and later in neonatology at the University Hospitals Leuven. He started as a staff member at the NICU University Hospitals Leuven in 1997 and became head of the NICU in 2007. The NICU of the University Hospitals Leuven currently has 35 NICU beds and 8 low care beds with a total of around 700 admissions each year. Patients are both preterm and term infants. There are special programs for congenital cardiopathies, ECMO, neonatal neurology, diaphragmatic hernia and other congenital malformations. He received a Clinical Doctoral Grant from the Fund of Scientific Research, Flanders and graduated as PhD in 2003 with the manuscript Non-invasive measurement of the cerebral and splanchnic circulation by near-infrared spectroscopy. (Acta Biomedica Lovaniensia 295; 2003). As member of the European Neonatal Brain Club he further specialised in neonatal neurology. Research in near-infrared spectroscopy and EEG in preterm and term infants is ongoing in the unit with a special collaboration with ESAT (Engineering department) for signal analysis and automatisation of EEG and NIRS interpretation. Recent research is also focused on perinatal asphyxia with collaborators in Leuven and Kinshasa. He has published 131 international articles. He is currently the President of the College Mother-child, section neonates and member of the board of BVN (Belgian society of Neonatology), VVK (Flemish society of pediatrics) and SPE (Study center perinatal epidemiology
Professor Craig White
Craig White is Divisional Clinical Lead, Healthcare Quality and Improvement Directorate, Scottish Government. He is a clinical and health psychologist. He has doctoral degrees in clinical psychology and psychological medicine and a Masters in Medical Law. He is a Fellow of the Royal College of Physicians of Edinburgh and of the British Psychological Society. Craig Chairs the Scottish Government’s Duty of Candour Implementation Advisory Group and the National Implementation Advisory Group for Palliative and End of Life Care, reflecting his close involvement with policy development and implementation support in respect of adverse events, complaints, governance and on palliative and end of life care. Prior to joining the Scottish Government full time in December 2013 he was Assistant Director and Caldicott Guardian in NHS Ayrshire and Arran. He is Honorary Professor with the College of Medical, Veterinary and Life Sciences at the University of Glasgow.
Professor Catherine Williamson
Catherine Williamson took up the role of Professor of Women’s Health at King’s College London in 2013. Between 2007 and 2013, she was Professor of Obstetric Medicine at Imperial College. She is a leading clinical researcher in maternal medicine in the UK and internationally. Her principal research focus is on the maternal and fetal aetiology and outcomes of a common liver disease of pregnant women, intrahepatic cholestasis of pregnancy (ICP). She is part of the UK team running a clinical trial to find the best treatments. She also runs a research programme investigating gestational signals that influence alterations in lipids, glucose and bile acids in pregnancy. The group also focusses on the influence of intrauterine environment on the subsequent health of the offspring. Catherine uses a large database to study the outcome of tumours of endocrine glands in pregnant women in the UK, with the aim of improving treatment for affected mothers and their unborn babies. She also works on prediction of diseases in pregnant women. Catherine is an assessor of maternal deaths in the UK. Professor Williamson receives referrals to the specialist obstetric medicine clinic at St Thomas’ Hospital from colleagues in the UK and internationally and regularly speaks about medical disorders of pregnancy at international courses and conferences.